BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1187 related articles for article (PubMed ID: 22425883)

  • 1. Responsiveness of the OARSI-OMERACT osteoarthritis pain and function measures.
    Bond M; Davis A; Lohmander S; Hawker G
    Osteoarthritis Cartilage; 2012 Jun; 20(6):541-7. PubMed ID: 22425883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychometric properties of the OARSI/OMERACT osteoarthritis pain and functional impairment scales: ICOAP, KOOS-PS and HOOS-PS.
    Ruyssen-Witrand A; Fernandez-Lopez CJ; Gossec L; Anract P; Courpied JP; Dougados M
    Clin Exp Rheumatol; 2011; 29(2):231-7. PubMed ID: 21470490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Responsiveness of the Intermittent and Constant Osteoarthritis Pain (ICOAP) scale in a trial of duloxetine for treatment of osteoarthritis knee pain.
    Risser RC; Hochberg MC; Gaynor PJ; D'Souza DN; Frakes EP
    Osteoarthritis Cartilage; 2013 May; 21(5):691-4. PubMed ID: 23485934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy, safety, and tolerability of the cyclooxygenase-inhibiting nitric oxide donator naproxcinod in treating osteoarthritis of the hip or knee.
    Karlsson J; Pivodic A; Aguirre D; Schnitzer TJ
    J Rheumatol; 2009 Jun; 36(6):1290-7. PubMed ID: 19411388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-cultural validation of the ICOAP and physical function short forms of the HOOS and KOOS in a multi-country study of patients with hip and knee osteoarthritis.
    Mehta SP; Sankar A; Venkataramanan V; Lohmander LS; Katz JN; Hawker GA; Gossec L; Roos EM; Maillefert JF; Kloppenburg M; Dougados M; Davis AM
    Osteoarthritis Cartilage; 2016 Dec; 24(12):2077-2081. PubMed ID: 27497697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative, validity and responsiveness of the HOOS-PS and KOOS-PS to the WOMAC physical function subscale in total joint replacement for osteoarthritis.
    Davis AM; Perruccio AV; Canizares M; Hawker GA; Roos EM; Maillefert JF; Lohmander LS
    Osteoarthritis Cartilage; 2009 Jul; 17(7):843-7. PubMed ID: 19215728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychometric properties of the French translation of the reduced KOOS and HOOS (KOOS-PS and HOOS-PS).
    Ornetti P; Perruccio AV; Roos EM; Lohmander LS; Davis AM; Maillefert JF
    Osteoarthritis Cartilage; 2009 Dec; 17(12):1604-8. PubMed ID: 19589400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of naproxcinod in the treatment of patients with osteoarthritis of the knee: a 13-week prospective, randomized, multicenter study.
    Schnitzer TJ; Kivitz A; Frayssinet H; Duquesroix B
    Osteoarthritis Cartilage; 2010 May; 18(5):629-39. PubMed ID: 20202489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of measurement properties of the P4 pain scale and disease specific pain measures in patients with knee osteoarthritis.
    Robbins SM; Rastogi R; Howard J; Rosedale R
    Osteoarthritis Cartilage; 2014 Jun; 22(6):805-12. PubMed ID: 24721460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reliability and clinically important improvement thresholds for osteoarthritis pain and function scales: a multicenter study.
    Singh JA; Luo R; Landon GC; Suarez-Almazor M
    J Rheumatol; 2014 Mar; 41(3):509-15. PubMed ID: 24429183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responsiveness of the electronic touch screen WOMAC 3.1 OA Index in a short term clinical trial with rofecoxib.
    Theiler R; Bischoff-Ferrari HA; Good M; Bellamy N
    Osteoarthritis Cartilage; 2004 Nov; 12(11):912-6. PubMed ID: 15501407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Greater reduction of knee than hip pain in osteoarthritis treated with naproxen, as evaluated by WOMAC and SF-36.
    Svensson O; Malmenäs M; Fajutrao L; Roos EM; Lohmander LS
    Ann Rheum Dis; 2006 Jun; 65(6):781-4. PubMed ID: 16269428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter, randomized, double-blind, active-controlled, parallel-group trial of the long-term (6-12 months) safety of acetaminophen in adult patients with osteoarthritis.
    Temple AR; Benson GD; Zinsenheim JR; Schweinle JE
    Clin Ther; 2006 Feb; 28(2):222-35. PubMed ID: 16678643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responsiveness of the Turkish KOOS-PS and HOOS-PS in knee and hip joint arthroplasty patients.
    Yilmaz Tasdelen O; Utkan A; Ceritoglu KU; Ozalp Ates FS; Bodur H
    J Back Musculoskelet Rehabil; 2020; 33(6):977-981. PubMed ID: 32144975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcultural adaptation and validation of the Chinese version of the intermittent and constant osteoarthritis pain (ICOAP) measure in patients with knee osteoarthritis.
    Zhang C; Liu DH; Qu YL; Jia ZY; Wang W; Li J; Xu WD
    Osteoarthritis Cartilage; 2017 Apr; 25(4):506-512. PubMed ID: 27914877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial.
    Balanescu AR; Feist E; Wolfram G; Davignon I; Smith MD; Brown MT; West CR
    Ann Rheum Dis; 2014 Sep; 73(9):1665-72. PubMed ID: 23852695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of tanezumab monotherapy or combined with non-steroidal anti-inflammatory drugs in the treatment of knee or hip osteoarthritis pain.
    Schnitzer TJ; Ekman EF; Spierings EL; Greenberg HS; Smith MD; Brown MT; West CR; Verburg KM
    Ann Rheum Dis; 2015 Jun; 74(6):1202-11. PubMed ID: 24625625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the responsiveness of the ICOAP following hip or knee replacement.
    Davis AM; Lohmander LS; Wong R; Venkataramanan V; Hawker GA
    Osteoarthritis Cartilage; 2010 Aug; 18(8):1043-5. PubMed ID: 20435154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.
    Kivitz A; Ma C; Ahdieh H; Galer BS
    Clin Ther; 2006 Mar; 28(3):352-64. PubMed ID: 16750450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OMERACT/OARSI initiative to define states of severity and indication for joint replacement in hip and knee osteoarthritis.
    Gossec L; Hawker G; Davis AM; Maillefert JF; Lohmander LS; Altman R; Cibere J; Conaghan PG; Hochberg MC; Jordan JM; Katz JN; March L; Mahomed N; Pavelka K; Roos EM; Suarez-Almazor ME; Zanoli G; Dougados M
    J Rheumatol; 2007 Jun; 34(6):1432-5. PubMed ID: 17552070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.